Becton, Dickinson and Co. | BDX - Selling And Administration Expenses




Becton, Dickinson and Co. reported $1.26B in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.

Selling And Administration Expenses Change Date
Abbott USD 2.91B 21M Dec/2024
Agilent USD 394M 1000K Oct/2024
Align Technology USD 434.14M 18.12M Sep/2024
Avanos Medical USD 74.3M 1.2M Sep/2024
Baxter International USD 754M 267M Sep/2024
Becton, Dickinson and Co. USD 1.26B 50M Sep/2024
Bio-Rad Laboratories USD 200.44M 4.72M Sep/2024
Boston Scientific USD 1.56B 116M Sep/2024
Cooper Companies USD 391.4M 10.3M Oct/2024
Danaher USD 1.84B 31M Sep/2024
Dentsply International USD 390M 9M Sep/2024
Dexcom USD 306.4M 26.3M Sep/2024
Edwards Lifesciences USD 421.4M 29.4M Sep/2024
Exact Sciences USD 411.85M 24.72M Sep/2024
Globus Medical USD 240.74M 2.62M Sep/2024
Hologic USD 249.2M 8.9M Sep/2024
Insulet USD 234.1M 11.7M Sep/2024
Integra LifeSciences USD 177.19M 18.28M Sep/2024
Intuitive Surgical USD 612.6M 102M Dec/2024
J&J USD 6.45B 971M Dec/2024
Masimo USD 184.8M 7.3M Sep/2024
Medtronic USD 2.75B 101M Oct/2024
Patterson Companies 283.28M 40K Oct/2024
Solventum Corp 701M 0 Sep/2024
Stryker USD 1.82B 31M Sep/2024
Tandem Diabetes Care USD 99.64M 5.4M Sep/2024
Teleflex USD 247.26M 3.37M Sep/2024
Terumo JPY 92.58B 424M Sep/2024
Thermo Fisher Scientific USD 1.74B 444M Sep/2024
Zimmer Biomet Holdings USD 709.7M 27.4M Sep/2024